The Scientific Malpractice of the Average

I was sitting in a booth with my friend Sarah (who is the only human being I know who actually enjoys reading the fine print on a car lease) when she detailed her recent, rather harrowing trip to the emergency room. She looked terrible. She had been given a standard prescription for a common medication meant to treat heart palpitations, only to find herself so dizzy and nauseated within three hours that she could not physically stand up. (I told her she should have just had a large glass of buttery Chardonnay, but she is far more responsible than I am.) It was a mess. A literal, floor-spinning mess.

The dosage she received was identical to the one prescribed to her husband, a man who happens to outweigh her by a solid eighty pounds. This would be fine if they were the same biological entity. They are not. (He also has the metabolic rate of a sloth, but that is a different column entirely.) This is not just a minor oversight. It is a symptom of a much larger, much stupider problem in modern medicine. We are treating half the population like they are just smaller versions of men. They are not. It is a one-size-fits-all approach that fits almost nobody. I checked.

The Data Gap is a Canyon

Most people believe that modern medicine is a cathedral of precision. It is not. It is often a series of educated guesses based on data that ignores sex entirely. However, the reality is far more chaotic than the brochures suggest. According to the FDA, women are nearly twice as likely as men to experience adverse drug reactions. Read that again. Twice as likely. (I find this statistic offensive, though my doctor says my blood pressure is high enough without me getting angry at government reports.)

We are living in an era where we can map the human genome, yet we still frequently fail to perform the basic task of separating data by sex. We can send rovers to Mars. (Yet I still cannot find a pair of socks that match on a Monday morning.) Despite these achievements, we frequently fail to perform the basic task of separating clinical data by sex. A 2024 report in the Journal of Women’s Health found that even in studies involving conditions that primarily affect women, the results are often not broken down by sex. This is not just a clerical error. It is a fundamental failure of the scientific method.

Consider the sheer volume of money we throw at research. We have spent decades pouring billions of dollars into medical research, only to come away with half the story. (I often wonder if those laboratory mice are as confused by the lack of representation as we are.) When researchers say a treatment is "safe and effective," they are often making a statement that is technically true for the group as a whole but dangerously false for the individuals within it. It is a statistical sleight of hand. It is dishonest. It is also quite expensive when it goes wrong.

Tractors and Luxury Cars

I recall talking to a contractor named Dave who was renovating my bathroom. (Dave is a man who treats a level like a holy relic.) Dave would never dream of mixing different types of plumbing pipes together because he knows they react differently to water pressure. I told my doctor that treating a woman's body based on male data is like trying to fix a luxury electric car using a manual for a diesel tractor. They are both vehicles, certainly, but the internal mechanics are fundamentally different. He stared at me with the weary expression of a man who has seen too many internet-informed patients. He was not amused. (I was, however, quite proud of the metaphor.)

If Dave, who spends his days in crawl spaces, understands the importance of material specificity, why do we struggle to apply this to human beings? It is about more than just weight. It is about hormones. It is about metabolism. It is about how our bodies process chemicals at the cellular level. When we ignore these variables, we are not practicing science. We are practicing a form of high-stakes gambling. Failing to acknowledge this is not just an oversight; it is a form of scientific malpractice that puts millions of people at risk every single day. It is not subtle. It is dangerous.

I once tried to fix my own lawnmower using a manual for a vintage motorbike. (It did not end well. My neighbor, Bob, still mentions the small fire I started whenever he sees me holding a wrench.) That is exactly what we are doing here. We are using the wrong manual for half of the population. We are saying that the convenience of the researcher is more important than the safety of the patient. (I do not know about you, but that makes me want to start throwing things.) It is a choice. We are choosing to be lazy with people's lives.

The Ghost of the Reference Man

For decades, the "Reference Man" has been the gold standard of medical research. He is seventy kilograms. He is male. He is the default. (And he really should be retired; he is exhausted and clearly does not speak for the rest of us.) This failure to separate data leads to what I call the "Evidence Gap." Doctors rely on clinical guidelines to make life-saving decisions. If those guidelines are based on aggregated data that skews male, the doctor is essentially flying blind when treating a female patient. This is not hyperbole. It is the current state of affairs.

For years, the symptoms of a heart attack in women were ignored because they did not match the "classic" symptoms found in men. (Women were literally being sent home from emergency rooms while having heart attacks because the data said their symptoms were not real.) This is the real-world consequence of failing to disaggregate data. It is not just an academic debate; it is a matter of life and death. We are treating the female experience as an outlier when it is, in fact, the norm for half the planet. It is absurd. It is a biological blind spot that we have collectively agreed to ignore.

The ethical breach occurs the moment a researcher decides that biological sex is too inconvenient to track. It is like trying to bake a cake but refusing to acknowledge that flour and sugar are different ingredients. You might get something that looks like a cake, but it will taste like disappointment and failure. We must also confront the fact that this is not just a legacy issue. Even today, many peer-reviewed journals do not require sex-disaggregated data for publication. We are still rewarding incomplete science with prestige and funding. We are paying for half-truths.

The Ethical Breach of Convenience

So, where do we go from here? The good news is that the tides are slowly turning. In 2016, the National Institutes of Health implemented the Sex as a Biological Variable policy. This policy requires researchers who receive federal funding to explain how they will account for sex in their study designs. But a policy is only as good as its enforcement. We need a culture shift in science where disaggregating data is not seen as an extra chore, but as the absolute minimum requirement for excellence. It is about the fundamental validity of the scientific method.

If you are conducting an experiment and you ignore a variable as significant as biological sex, your results are inherently flawed. It is important to understand that this is not just about fairness. It is about the accuracy of the results. We need to become better advocates for ourselves. The next time a doctor gives you a new prescription, ask them: "Was this drug tested on people of my biological sex?" and "Did the study show different results for men and women?" (You might get a blank stare, but that blank stare is a very useful piece of information.)

At the end of the day, the data does not lie, but the way we choose to present it certainly can. By failing to separate information by sex, the scientific community has spent decades telling a half-truth that masquerades as universal certainty. This is not just a problem for researchers in white coats; it is a problem that sits on our bedside tables in the form of pill bottles and lives in our medical records in the form of misdiagnoses. We deserve the truth, in all its disaggregated glory. We deserve better than a guess. We deserve science that actually sees us.

🤔 Did You Know?

Women were not legally required to be included in NIH-funded clinical trials until the passage of the NIH Revitalization Act in 1993. Before that, researchers could simply choose to exclude women because their hormonal cycles were considered too "complicated" for clean data. (Apparently, being complicated is a medical disqualification.)

Frequently Asked Questions

❓ What is the difference between sex and gender in data disaggregation?

For the purposes of clinical data disaggregation, we are primarily concerned with biological sex because that is what determines the physiological reaction to a treatment. This includes things like liver enzyme activity and kidney filtration rates. (Of course, gender identity also affects health outcomes due to social factors, but that is a separate layer of analysis that researchers should also be tracking.) Both are important, but they serve different roles in the lab.

❓ Is it more expensive for researchers to disaggregate their data?

Here is the thing about money in science: doing it right the first time is always cheaper than dealing with the fallout of doing it wrong. While it might require a slightly larger sample size or more time for analysis to ensure both males and females are adequately represented, the cost is negligible compared to the price of a drug recall or a series of preventable adverse reactions. If a research project is too underfunded to look at both sexes, then the research itself is probably not robust enough to be trusted. We should stop looking at sex disaggregation as an added expense and start seeing it as a baseline requirement for a valid study.

❓ How do these data gaps affect my daily life?

The answer to this is found in your medicine cabinet and your doctor's office. Every time you take a painkiller, a blood pressure medication, or a statin, you are participating in the results of these clinical trials. If those trials did not separate data by sex, your doctor might be prescribing you a dose that is either ineffective or unnecessarily risky. For example, because auto-immune diseases affect women at much higher rates, a lack of sex-disaggregated data in the early stages of research can lead to long delays in finding effective treatments. It is a practical problem that touches almost every aspect of your healthcare.

❓ Are there any medical fields that are doing this well?

I would say that cardiology is finally starting to wake up, largely because the evidence of sex differences in heart disease became too overwhelming to ignore. We are also seeing better practices in fields like oncology, where the genetic and hormonal drivers of cancer are being studied with a much sharper focus on sex. However, we are still lagging behind in areas like neuroscience and immunology. It is a bit of a mixed bag, to be honest. Some researchers are leading the charge, while others are still clutching their 1970s textbooks and hoping nobody notices the missing data.

❓ What can I do to help change this system?

The most powerful tool you have is your voice and your curiosity. When you read a news article about a new medical breakthrough, look for the details about who was in the study. If the article does not mention the sex of the participants, write a polite (or slightly grumpy, I will not judge) email to the author asking for that information. Change happens when the people who are being excluded start making it impossible to ignore them. We have the power to demand better science, and it starts with asking the right questions. Do not be afraid to be the loudest person in the waiting room.

References

Disclaimer: This article is for informational purposes only and does not constitute professional medical advice. The content is meant to highlight broad trends in clinical research and ethical data practices. Always consult with a qualified healthcare professional regarding personal medical decisions, dosages, or health conditions.